JAZZ

178.55

0.98% -1.77

Dopo l'orario di chiusura: 178.55

Jazz Pharmaceuticals Plc (JAZZ)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$180.32

Aprire:

$181.56

Volume 24 ore:

827.48K

Relative Volume:

0.81

Capitalizzazione di mercato:

$10.99B

Reddito:

$4.27B

Utile/perdita netta:

$-356.15M

Rapporto P/E:

-29.91

EPS:

-5.9702

Flusso di cassa netto:

$1.19B

1 W Prestazione:

-1.90%

1M Prestazione:

+7.36%

6M Prestazione:

+41.53%

1 anno Prestazione:

+31.24%

Intervallo 1D:

$177.58

$183.90

Intervallo di 1 settimana:

$177.58

$188.62

Portata 52W:

$95.49

$198.00

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Nome

Jazz Pharmaceuticals Plc

Settore

Healthcare (1116)

Industria

Biotechnology (621)

Telefono

353-1-634-7800

Indirizzo

FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN

Dipendente

2,890

Cinguettio

@jazzpharma

Prossima data di guadagno

2026-02-24

Ultimi documenti SEC

JAZZ's Discussions on Twitter

Compare JAZZ vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
JAZZ Jazz Pharmaceuticals Plc	178.55	10.99B	4.27B	-356.15M	1.19B	-5.9702
VRTX Vertex Pharmaceuticals Inc	469.34	119.23B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	745.77	78.84B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	700.45	43.35B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	313.41	41.57B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	284.05	31.51B	5.36B	287.73M	924.18M	2.5229

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-27	Iniziato	Barclays	Overweight
2025-11-24	Downgrade	UBS	Buy → Neutral
2025-07-15	Iniziato	Deutsche Bank	Buy
2025-03-07	Aggiornamento	UBS	Neutral → Buy
2025-02-26	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2025-02-13	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2024-12-12	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2024-06-05	Iniziato	Goldman	Buy
2024-01-03	Iniziato	Robert W. Baird	Outperform
2023-11-27	Downgrade	UBS	Buy → Neutral
2023-09-29	Iniziato	Raymond James	Mkt Perform
2023-06-12	Ripresa	Wells Fargo	Equal Weight
2022-12-09	Aggiornamento	Goldman	Neutral → Buy
2022-06-14	Iniziato	UBS	Buy
2022-04-06	Downgrade	Goldman	Buy → Neutral
2021-11-19	Ripresa	Goldman	Buy
2021-10-07	Ripresa	Jefferies	Buy
2021-10-05	Iniziato	Citigroup	Buy
2021-09-23	Iniziato	Needham	Buy
2021-05-19	Ripresa	JP Morgan	Overweight
2021-04-07	Ripresa	RBC Capital Mkts	Outperform
2021-02-05	Reiterato	H.C. Wainwright	Buy
2021-02-03	Aggiornamento	Piper Sandler	Neutral → Overweight
2021-01-29	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2020-12-16	Iniziato	UBS	Buy
2020-11-03	Reiterato	H.C. Wainwright	Buy
2020-10-09	Reiterato	H.C. Wainwright	Buy
2020-09-14	Downgrade	Goldman	Neutral → Sell
2020-09-14	Ripresa	JP Morgan	Overweight
2020-08-06	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2020-07-28	Aggiornamento	Wolfe Research	Peer Perform → Outperform
2020-07-23	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-04-06	Iniziato	Jefferies	Buy
2020-03-12	Aggiornamento	Bernstein	Mkt Perform → Outperform
2020-01-08	Iniziato	Goldman	Neutral
2019-08-21	Downgrade	Piper Jaffray	Overweight → Neutral
2019-06-11	Iniziato	Barclays	Overweight
2019-03-20	Iniziato	SunTrust	Buy
2018-12-14	Iniziato	Wolfe Research	Peer Perform
2018-11-08	Reiterato	B. Riley FBR	Buy
2018-08-08	Reiterato	Stifel	Buy
2018-07-11	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2018-03-23	Reiterato	H.C. Wainwright	Neutral
2018-03-19	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight

Mostra tutto

Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie

Mar 13, 2026

AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead? - TradingView

Mar 13, 2026

Mar 12, 2026

Jazz Pharmaceuticals (JAZZ) Price Forecast: Multi-Year Base Signals Breakout Potential - FXEmpire

Mar 12, 2026

Jazz Pharmaceuticals at Barclays Conference: Strategic Growth Insights By Investing.com - Investing.com South Africa

Mar 12, 2026

Jazz Pharmaceuticals at Barclays Conference: Strategic Growth Insights - Investing.com Nigeria

Mar 12, 2026

Capital World Investors Increases Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat

Mar 12, 2026

Mar 11, 2026

A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Record Revenue And Supportive Barclays Commentary - simplywall.st

Mar 11, 2026

Mar 10, 2026

Jazz Pharmaceuticals Stock at $185: Here’s Why Analysts See a New All-Time High in 2026 - TIKR.com

Mar 10, 2026

Mar 09, 2026

Jazz’s 2025 Net Loss and 2026 Outlook Might Change The Case For Investing In JAZZ - simplywall.st

Mar 09, 2026

Jazz Pharmaceuticals (NASDAQ:JAZZ) CAO Sells $235,443.78 in Stock - MarketBeat

Mar 09, 2026

Tax-withholding share disposition by Jazz Pharmaceuticals (JAZZ) director - Stock Titan

Mar 09, 2026

Jazz Pharmaceuticals (JAZZ) CFO reports tax-withholding share disposition - Stock Titan

Mar 09, 2026

Jazz Pharmaceuticals (JAZZ) EVP has 2,503 shares withheld to cover RSU taxes - Stock Titan

Mar 09, 2026

Barclays reiterates Jazz Pharmaceuticals stock rating on CNS strength - Investing.com Nigeria

Mar 09, 2026

Patricia Carr (NASDAQ: JAZZ) files Form 144 showing recent share sales - Stock Titan

Mar 09, 2026

JAZZ or ACAD: Which Is the Better Value Stock Right Now? - Yahoo Finance

Mar 09, 2026

S&P 500 Futures Fall in Premarket Trading; Jazz Pharmaceuticals, Live Nation Ent Lead - Barron's

Mar 09, 2026

Mar 08, 2026